HomeALIVUS • NSE
add
Alivus Life Sciences Ltd
Previous close
₹1,064.90
Day range
₹1,050.85 - ₹1,084.70
Year range
₹819.00 - ₹1,225.10
Market cap
131.40B INR
Avg Volume
74.80K
P/E ratio
24.20
Dividend yield
0.47%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 6.73B | 4.84% |
Operating expense | 1.85B | 1.89% |
Net income | 1.50B | 9.71% |
Net profit margin | 22.33 | 4.64% |
Earnings per share | 13.80 | 23.88% |
EBITDA | 2.25B | 20.58% |
Effective tax rate | 24.26% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.53B | 46.27% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 30.15B | — |
Shares outstanding | 122.66M | — |
Price to book | 4.33 | — |
Return on assets | — | — |
Return on capital | 17.20% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.50B | 9.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2001
Website
Employees
2,203
